Trial Search
Current Search Criteria:
Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff
N/ACOVID-19 is a pathology linked to the SARS-CoV-2 virus, a new virus of the ...
Status
Completed
Location
Hôpital d'Instuction des Armées Percy
Start Date
2020-06-04
Trial ID
NCT04408001
Treatments Being Tested
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
N/AStudy Aim is creation of the Hospital Register of patients with heart failu...
Status
Active Not Recruiting
Location
Moscow State Clinical Hospital named after V.V. Veresaev
Start Date
2023-09-01
Trial ID
NCT06114498
Treatments Being Tested
Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels
N/AWe plan to investigate the serum elevation of 25(OH)D under UVB nb and UVA1...
Status
Completed
Location
Dermatology Department, University Hospital
Start Date
2009-03
Trial ID
NCT00910260
Treatments Being Tested
A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis
N/AImmunothrombosis has recently been used to describe the responses/mechanism...
Status
Completed
Location
the Affiliated Hospital of Qingdao University
Start Date
2013-01-01
Trial ID
NCT05541562
Treatments Being Tested
Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS
N/AValidating a peptide-based laboratory test enabling the measurement of Tysa...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2016-10
Trial ID
NCT02965170
Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis
NAA total of 100 adult volunteers of both sexes will be enrolled in the proje...
Status
Recruiting
Location
Oral Surgery Department Wroclaw Medical University
Start Date
2025-07-01
Trial ID
NCT07012915
Treatments Being Tested
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
PHASE1This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
PHASE2Background: The disease follicular lymphoma (FL) develops when the body ma...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-22
Trial ID
NCT03789240
Anti-alpha-actinin Antibodies and Lupus Nephritis Activity
N/ALupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
A Prospective, Mono-center, Interventional Study Evaluating the Effect of One Year Initial Care by Hygieno-dietary Advices With or Without Phlebotomy on Glycemia After at Least 5 Years in Patients With Dysmetabolic Iron Overload Syndrome
NAA prospective, mono-center, interventional study evaluating the effect of o...
Status
Completed
Location
CHU Rennes
Start Date
2019-06-11
Trial ID
NCT03942432
Treatments Being Tested